Roche Acquires Promedior for Up to US$1.4 B
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)
Published: 21 Nov-2019
DOI: 10.3833/pdr.v2019.i11.2470 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
A year after Bristol-Myers Squibb declined an option to acquire it in 2018, Promedior has found another buyer in Roche which has agreed to pay up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS